Condition: Diagnosis of Cancer of Various Organs · Sponsor: ClearNote Health
ClearNote Health is developing a test from whole blood for the early detection of multiple cancers. The goal of this study is to employ genomics, epigenomics and proteomics methodology for the detection of cancer signal in the blood of subjects with solid tumors.
This description comes directly from the study's public registry record.
Melissa Peters, MA, PMP, CCRC · 619-277-2160 · mpeters@clearnotehealth.com
Always discuss trial participation with your own doctor first.
| ClearNote Health, Inc. | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03869814